Researchers found that inhibiting the enzyme TYK2 may reduce the harmful accumulation of tau protein in Alzheimer’s disease, offering a potential treatment approach. Researchers from Baylor College of Medicine, the Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital, and partner institutions have discovered that the enzyme TYK2 converts the normal tau protein […]
Source link